TTC5
Basic information
Region (hg38): 14:20256558-20305960
Links
Phenotypes
GenCC
Source:
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism (Limited), mode of inheritance: AR
- neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism (Strong), mode of inheritance: AR
- neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 29302074; 32439809 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (35 variants)
- not_provided (15 variants)
- Neurodevelopmental_disorder_with_cerebral_atrophy_and_variable_facial_dysmorphism (15 variants)
- Neurodevelopmental_delay (1 variants)
- TTC5-related_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTC5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000138376.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | |||||
| missense | 41 | 48 | ||||
| nonsense | 7 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 5 | 5 | 44 | 8 | 1 |
Highest pathogenic variant AF is 0.00004276985
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TTC5 | protein_coding | protein_coding | ENST00000258821 | 10 | 49437 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00000462 | 0.992 | 125699 | 0 | 49 | 125748 | 0.000195 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.532 | 216 | 239 | 0.903 | 0.0000124 | 2843 |
| Missense in Polyphen | 32 | 54.571 | 0.58639 | 653 | ||
| Synonymous | -0.0556 | 94 | 93.3 | 1.01 | 0.00000466 | 874 |
| Loss of Function | 2.37 | 13 | 26.0 | 0.499 | 0.00000150 | 277 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000124 | 0.000124 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000761 | 0.000761 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000242 | 0.000237 |
| Middle Eastern | 0.000761 | 0.000761 |
| South Asian | 0.000100 | 0.0000980 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter protein involved in p53/TP53 response that acts by regulating and mediating the assembly of multi-protein complexes. Required to facilitate the interaction between JMY and p300/EP300 and increase p53/TP53-dependent transcription and apoptosis. Prevents p53/TP53 degradation by MDM2 (By similarity). {ECO:0000250}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Regulation of TP53 Activity through Methylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53;p53 pathway
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.565
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.96
Haploinsufficiency Scores
- pHI
- 0.206
- hipred
- N
- hipred_score
- 0.372
- ghis
- 0.538
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0324
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ttc5
- Phenotype
Gene ontology
- Biological process
- DNA repair;positive regulation of transcription by RNA polymerase II;regulation of signal transduction by p53 class mediator
- Cellular component
- nucleoplasm;cytoplasm
- Molecular function
- DNA binding;chromatin binding;protein binding